Biognosys ^Company

Founded in 2008 in Zurich, Switzerland, Biognosys is a proteomics company offering mass spectrometry-based protein analysis platforms. Its proprietary technologies support biomarker discovery, drug development, and clinical proteomics for pharma and biotech clients. Acquired by Bruker in 2023, Biognosys remains a leader in precision proteomics. (biognosys.com)